Minchun Li is a Patent Attorney who has been dedicated to intellectual property services since 2013, serving both Chinese and international clients. She is highly proficient in a wide range of patent-related activities, including reviewing and finalizing patent application documents, prosecuting patent applications, advising clients on patent matters, responding to Office Actions issued by the CNIPA and conducting patent reexamination and invalidation affairs. In pharmaceutical cases she is familiar with the use of dosage regimen claims to define medical use and with the corresponding inventive-step arguments, and in biotechnology cases with the drafting and formality requirements specific to the field, including ST.26 sequence listings and the deposit of biological material. She also handles plant variety protection. Her professional expertise covers a broad array of technical fields, including biochemistry, pharmaceuticals, and bioagriculture, as well as chemistry and materials science, environment and energy, and agriculture and food technology. Over her career she has handled more than 1,000 patent applications, acting for global pharmaceutical companies such as MacroGenics, Takeda Pharmaceutical, Mylan Ireland and Kolon TissueGene, for leading universities such as ETH Zurich, Aarhus University and Queensland University of Technology, and for other biotechnology and agricultural technology companies.